ISIS 14803
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ISIS 14803, covering 2022-12-05 to 2022-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs [Phase 1, Phase 2]